Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3956626
Max Phase: Preclinical
Molecular Formula: C56H78N16O13
Molecular Weight: 1183.34
Molecule Type: Small molecule
Associated Items:
ID: ALA3956626
Max Phase: Preclinical
Molecular Formula: C56H78N16O13
Molecular Weight: 1183.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC(=N)NCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)NNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)CN(C)C(=O)[C@@H](Cc1ccc(O)cc1)NC(C)=O)[C@@H](C)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(N)=O
Standard InChI: InChI=1S/C56H78N16O13/c1-30(2)23-41(50(80)65-39(17-12-22-61-55(59)60-5)49(79)66-40(48(58)78)26-35-28-62-38-16-11-10-15-37(35)38)68-56(85)71-70-52(82)42(24-33-13-8-7-9-14-33)67-53(83)47(31(3)73)69-51(81)43(27-45(57)76)64-46(77)29-72(6)54(84)44(63-32(4)74)25-34-18-20-36(75)21-19-34/h7-11,13-16,18-21,28,30-31,39-44,47,62,73,75H,12,17,22-27,29H2,1-6H3,(H2,57,76)(H2,58,78)(H,63,74)(H,64,77)(H,65,80)(H,66,79)(H,67,83)(H,69,81)(H,70,82)(H3,59,60,61)(H2,68,71,85)/t31-,39+,40+,41+,42+,43+,44-,47+/m1/s1
Standard InChI Key: QAJQTVRAXDIAKV-YHJINNEHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1183.34 | Molecular Weight (Monoisotopic): 1182.5934 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Nishizawa N, Takatsu Y, Kumano S, Kiba A, Ban J, Tsutsumi S, Matsui H, Matsumoto SI, Yamaguchi M, Ikeda Y, Kusaka M, Ohtaki T, Itoh F, Asami T.. (2016) Design and Synthesis of an Investigational Nonapeptide KISS1 Receptor (KISS1R) Agonist, Ac-d-Tyr-Hydroxyproline (Hyp)-Asn-Thr-Phe-azaGly-Leu-Arg(Me)-Trp-NH2 (TAK-448), with Highly Potent Testosterone-Suppressive Activity and Excellent Water Solubility., 59 (19): [PMID:27589480] [10.1021/acs.jmedchem.6b00379] |
Source(1):